IPAD-DB ID | C01309 |
Name | Syringetin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 7 H 1 4 O 8 |
Molecular Weight | 346.3 g/mol |
IUPAC Name | 3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-dimethoxyphenyl)chromen-4-one |
InChI | InChI=1S/C17H14O8/c1-23-11-3-7(4-12(24-2)14(11)20)17-16(22)15(21)13-9(19)5-8(18)6-10(13)25-17/h3-6, 18-20, 22H, 1-2H3 |
InChIKey | UZMAPBJVXOGOFT-UHFFFAOYSA-N |
Canonical SMILES | COC1=CC(=CC(=C1O)OC)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O |
PubChem CID | 5281953 |
DrugBank Accession Number | - |
CAS Registry Number | 4423-37-4 |
Molecular Weight(Computed by SwissADME) | 346.29 |
Hac(Computed by SwissADME) | 25 |
Volume(Computed by ADMETlab 2.0) | 326.149 |
Density(Computed by ADMETlab 2.0) | 1.061 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 8 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.167 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.817 |
LogD(Computed by ADMETlab 2.0) | 2.095 |
logP(Computed by ADMETlab 2.0) | 2.463 |
TPSA(Computed by SwissADME) | 129.59 |
Hbond Acceptor(Computed by SwissADME) | 8 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.11 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |